Skandinaviska Enskilda Banken (SEB)
WINT

Skandinaviska Enskilda Banken (SEB)’s Windtree Therapeutics WINT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2
Closed -$19K – 934
2022
Q4 		$19K Hold
2
– – ﹤0.01% 838
2022
Q3 		$33K Hold
2
– – ﹤0.01% 866
2022
Q2 		$46K Hold
2
– – ﹤0.01% 968
2022
Q1 		$126K Hold
2
– – ﹤0.01% 920
2021
Q4 		$157K Hold
2
– – ﹤0.01% 921
2021
Q3 		$228K Hold
2
– – ﹤0.01% 915
2021
Q2 		$219K Buy
+2
New +$195K ﹤0.01% 951

Other funds holding WINT

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s WINT Position: Q1 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Windtree Therapeutics (WINT) in Q1 2023, closing a stake of 2 shares — an estimated $19K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in WINT in Q2 2021 and held it in 7 quarters. The position peaked at $228K in Q3 2021. 2 funds tracked by Wall St. Rank hold WINT as of Q1 2023.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Windtree Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 2 Windtree Therapeutics shares in Q1 2023, an estimated $19K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Windtree Therapeutics in Q2 2021 and held it in 7 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Windtree Therapeutics position peaked at $228K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q1 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2023, filed 11 May 2023.